The Priority Review

Clinical trials Brief

GlaxoSmithKline posts results of Phase 3 B-Well 2 study of bepirovirsen in chronic hepatitis B

The study enrolled 857 participants and completed primary data collection on November 3, 2025. Results were first posted on ClinicalTrials.gov on November 20, 2026.

Primary source

ClinicalTrials.gov results record, November 20, 2026

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

Read the source: Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) clinicaltrials.gov

Machine-summarized from the source above; not independently reported. How we use automation